Sanofi
CIK 1121404 · last filed 2021-09-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.49B
Companies
11
Total Filings
65
Lifetime Open-Market Net
-$2.44B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Translate Bio, Inc. (TBIO) Delisted | 10%+ Owner | 3,064,003 | $0.00 | $306 | $2.74B | 1 | 2021-09-14 |
| Icosavax, Inc. (ICVX) Delisted | 10%+ Owner | 3,155,169 | $15.31 | $48.31M | $1.00M | 1 | 2021-08-02 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 438,875 | $4.00 | $1.76M | $1.30M | 1 | 2020-07-29 |
| REGN | 10%+ Owner | 279,766 | $695.42 | $194.55M | -$9.52B | 46 | 2020-06-11 |
| FULC | 10%+ Owner | 464,285 | $3.62 | $1.68M | $1.50M | 1 | 2019-07-23 |
| MyoKardia, Inc. (MYOK) Delisted | 10%+ Owner | 0 | — | — | -$121.48M | 5 | 2019-02-15 |
| ALNY | 10%+ Owner | 10,554,134 | $286.62 | $3.03B | $1.98B | 6 | 2017-06-01 |
| VYGR | 2,352,941 | $3.00 | $7.06M | $1.75M | 1 | 2015-11-18 | |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 42,115 | $8.16 | $343.7K | $10.00M | 1 | 2014-02-05 |
| HUMANIGEN, INC (KBIO) Delisted | 579,030 | — | — | $700.0K | 1 | 2013-02-07 | |
| GENZ | 10%+ Owner | 187,986,225 | $38.61 | $7.26B | $2.48B | 1 | 2011-04-08 |
Recent Filings · Page 6 of 7
65 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-03-25 | REGN | Buy (P) | +306,945 | $94.51M | EDGAR |
| 2014-03-21 | REGN | Buy (P) | +67,703 | $22.23M | EDGAR |
| 2014-03-18 | REGN | Buy (P) | +115,711 | $38.01M | EDGAR |
| 2014-03-14 | REGN | Buy (P) | +220,995 | $73.96M | EDGAR |
| 2014-03-12 | REGN | Buy (P) | +380,532 | $125.73M | EDGAR |
| 2014-03-10 | REGN | Buy (P) | +150,277 | $49.40M | EDGAR |
| 2014-03-10 | REGN | Buy (P) | +241,818 | $80.41M | EDGAR |
| 2014-03-05 | REGN | Buy (P) | +251,594 | $85.07M | EDGAR |
| 2014-02-10 | REGN | Buy (P) | +168,511 | $48.33M | EDGAR |
| 2014-02-06 | REGN | Buy (P) | +397,264 | $112.87M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.